Discovery of a second, distinct development pattern of leukemic conversion from paroxysmal nocturnal hemoglobinuria

Area of Science:

• Hematology
• Oncology

Background:

• Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal hematopoietic stem cell disorder.
• Leukemic conversion, particularly to acute myeloid leukemia (AML), is a known complication of PNH, occurring in 0.6-2.9% of cases.
• The M6 subtype of AML (AML-M6) is frequently associated with PNH leukemic transformation.

Purpose of the Study:

• To investigate the distinct patterns of leukemic conversion in patients with paroxysmal nocturnal hemoglobinuria (PNH).
• To analyze the relationship between PNH clones and leukemic cells during the progression to acute myeloid leukemia (AML).

Main Methods:

• Literature review of PNH cases with leukemic conversion.
• Case analysis of patients with concomitant PNH and AML-M6.
• Flow cytometry to analyze cell surface markers (CD55, CD59) on PNH clones and leukemic blast cells.

Main Results:

• Two distinct patterns of leukemic conversion from PNH were identified.
• Type 1: Leukemic clones derived from non-PNH clones; PNH phenotype diminished.
• Type 2: Coexistence of leukemic cells and PNH clones; CD34-positive blast cells showed deficiency in CD55 and CD59, indicating PNH clone progression into malignancy.

Conclusions:

• Leukemic conversion from PNH to AML-M6 occurs via two distinct pathways.
• Type 2 pattern highlights the rare but significant progression of PNH clones into overt malignancies.
• Understanding these patterns is crucial for managing PNH patients at risk of leukemic transformation.